Global Peritoneal Dialysis Market - 2025-2033
Overview
The global peritoneal dialysis market reached US$ 4.85 billion in 2024 and is expected to reach US$ 9.16 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
Peritoneal dialysis is a medical treatment used to remove waste products and excess fluids from the body when the kidneys are no longer functioning properly. It is one of the two main types of dialysis, the other being hemodialysis. Unlike hemodialysis, which filters blood outside the body, peritoneal dialysis uses the patient's peritoneum (the lining of the abdominal cavity) as a natural filter to perform the dialysis process.
Peritoneal dialysis offers a personalized and flexible approach to dialysis, utilizing the body’s natural filtering system. It is often chosen by patients who are looking for a more autonomous treatment option or those who have medical conditions that preclude them from receiving hemodialysis. However, careful management is required to prevent complications such as infection and to ensure the effectiveness of the dialysis process.
Market Dynamics: Drivers & Restraints
Rising advancements in peritoneal dialysis are significantly driving the peritoneal dialysis market growth
The rising advancements in peritoneal dialysis are playing a pivotal role in the growth of the peritoneal dialysis market. These advancements are making the treatment more efficient, accessible, and patient-friendly, which in turn boosts the adoption of peritoneal dialysis over traditional hemodialysis.
There have been developments in peritoneal dialysis fluids, which are now more effective in removing toxins and reducing complications such as infections. Companies like Baxter, Mitra Industries, and Fresenius Medical Care have introduced advanced PD solutions that increase treatment efficacy and improve patient outcomes.
For instance, in March 2024, Mitra Industries launched its innovative triple-chambered peritoneal dialysis (PD) bag that has a near-neutral pH and low glucose degradation products (GDPs). The use of this bag will help nephrologists enhance patient care and improve outcomes. The conventional PD solutions have acidic pH, which has a deleterious effect on the functionality of the peritoneal membrane, the lifeline of PD.
New advancements in technology, like wearables, allow for better customization of the treatment. For instance, in June 2023, AWAK Technologies and Singapore General Hospital launched a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an Automated Wearable Artificial Kidney Peritoneal Dialysis device.
The risk of infections associated with peritoneal dialysis is hampering the market growth
The risk of infections associated with peritoneal dialysis (PD) significantly hampers the growth of the peritoneal dialysis market. While PD offers many advantages, such as being a more flexible, home-based treatment, the risk of infection, particularly peritonitis (inflammation of the peritoneum), remains a serious concern.
Peritonitis is one of the most common and severe complications of PD. It occurs when bacteria or fungi enter the peritoneal cavity, often through the catheter. Peritonitis can lead to hospitalization, extended treatment periods, and sometimes the need to switch to hemodialysis if it is not controlled effectively. This risk makes some patients hesitant to choose PD, especially when they weigh the possibility of infections against the convenience of home treatment.
The perceived risk of infection is a key reason why some patients and healthcare providers prefer hemodialysis over PD. Hemodialysis, although less convenient, is performed in a controlled clinical environment under strict medical supervision, thus reducing the risk of infections. The fear of infection and the management challenges associated with PD, especially for elderly or immunocompromised patients, can prevent wider adoption.
Segment Analysis
The global peritoneal dialysis market is segmented based on type, product type, end-user, and region.
Type:
The continuous ambulatory peritoneal dialysis (CAPD) segment is expected to dominate the peritoneal dialysis market with the highest market share
CAPD is peritoneal dialysis that can be done manually, without a machine, throughout the day. Continuous ambulatory peritoneal dialysis (CAPD) is done to remove wastes, chemicals, and extra fluid from the patient's body. During CAPD, a liquid called dialysate is put into the abdomen through a catheter (thin tube). The dialysate pulls wastes, chemicals, and extra fluid from blood through the peritoneum.
After the fluid is allowed to interact with the patient’s capillary blood, it is removed through the same permanent catheter, carrying with it the waste products like urea and creatinine. The procedure is repeated manually three times a day. Once started, CAPD has to be continued lifelong or till a renal transplantation is carried out. It offers the advantages of greater clearance of higher molecular-weight substances than during hemodialysis, good control of blood pressure, marked improvement of anemia, and unrestricted diet.
CAPD is perhaps the most uncomplicated method of carrying out dialysis as it involves the manual instillation of up to 3 L of dialysis fluid in the peritoneal cavity through an indwelling abdominal catheter four to five times a day. This typically means three or four short dwells during the day and a long dwell overnight. In adults, the total volume of fluid exchanged in a day typically ranges from 8 to 10 L. Thus, dialysis occurs continuously throughout the entire 24-hour period, and patients are free to engage in daily activities between exchanges.
Geographical Analysis
Europe is expected to hold a significant position in the global peritoneal dialysis market with the highest market share
Europe has seen significant advancements in peritoneal dialysis (PD) over the years, with increasing adoption due to its patient-friendly nature and the growing need for kidney care solutions. The region benefits from strong regulatory frameworks, which ensure high-quality standards for medical treatments, including PD.
Additionally, healthcare providers are increasingly focusing on improving patient outcomes by offering a range of innovative PD products and services. Despite challenges such as disparities in access to care across different countries, there has been a steady growth in PD usage, driven by factors such as patient preference for home-based care, cost-effectiveness, and a focus on improving quality of life.
As the European population ages and the prevalence of chronic kidney disease rises, the demand for effective and patient-centered treatments like PD will increase. The increasing prevalence of chronic kidney disease (CKD) in Europe significantly drives the demand for peritoneal dialysis (PD).
For instance, according to a report by the European Parliament in 2022, approximately 100 million individuals are affected by CKD across the European continent, and projections indicate that CKD will become the fifth leading cause of death globally by 2040. To avoid the risks of end-stage renal disease, individuals are expected to increase the adoption of peritoneal dialysis, which is considered a comfortable treatment.
Competitive Landscape
Top companies in the peritoneal dialysis market include Baxter, Fresenius Medical Care AG, BD, B. Braun Medical Inc., Mozarc Medical Holding LLC., Terumo Corporation, MITRA, Renax Biomedical Tech. Co., Ltd., Medionics, Diener Precision Pumps Ltd., and others.
Why Purchase the Report?
Target Audience 2024
The global peritoneal dialysis market reached US$ 4.85 billion in 2024 and is expected to reach US$ 9.16 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
Peritoneal dialysis is a medical treatment used to remove waste products and excess fluids from the body when the kidneys are no longer functioning properly. It is one of the two main types of dialysis, the other being hemodialysis. Unlike hemodialysis, which filters blood outside the body, peritoneal dialysis uses the patient's peritoneum (the lining of the abdominal cavity) as a natural filter to perform the dialysis process.
Peritoneal dialysis offers a personalized and flexible approach to dialysis, utilizing the body’s natural filtering system. It is often chosen by patients who are looking for a more autonomous treatment option or those who have medical conditions that preclude them from receiving hemodialysis. However, careful management is required to prevent complications such as infection and to ensure the effectiveness of the dialysis process.
Market Dynamics: Drivers & Restraints
Rising advancements in peritoneal dialysis are significantly driving the peritoneal dialysis market growth
The rising advancements in peritoneal dialysis are playing a pivotal role in the growth of the peritoneal dialysis market. These advancements are making the treatment more efficient, accessible, and patient-friendly, which in turn boosts the adoption of peritoneal dialysis over traditional hemodialysis.
There have been developments in peritoneal dialysis fluids, which are now more effective in removing toxins and reducing complications such as infections. Companies like Baxter, Mitra Industries, and Fresenius Medical Care have introduced advanced PD solutions that increase treatment efficacy and improve patient outcomes.
For instance, in March 2024, Mitra Industries launched its innovative triple-chambered peritoneal dialysis (PD) bag that has a near-neutral pH and low glucose degradation products (GDPs). The use of this bag will help nephrologists enhance patient care and improve outcomes. The conventional PD solutions have acidic pH, which has a deleterious effect on the functionality of the peritoneal membrane, the lifeline of PD.
New advancements in technology, like wearables, allow for better customization of the treatment. For instance, in June 2023, AWAK Technologies and Singapore General Hospital launched a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an Automated Wearable Artificial Kidney Peritoneal Dialysis device.
The risk of infections associated with peritoneal dialysis is hampering the market growth
The risk of infections associated with peritoneal dialysis (PD) significantly hampers the growth of the peritoneal dialysis market. While PD offers many advantages, such as being a more flexible, home-based treatment, the risk of infection, particularly peritonitis (inflammation of the peritoneum), remains a serious concern.
Peritonitis is one of the most common and severe complications of PD. It occurs when bacteria or fungi enter the peritoneal cavity, often through the catheter. Peritonitis can lead to hospitalization, extended treatment periods, and sometimes the need to switch to hemodialysis if it is not controlled effectively. This risk makes some patients hesitant to choose PD, especially when they weigh the possibility of infections against the convenience of home treatment.
The perceived risk of infection is a key reason why some patients and healthcare providers prefer hemodialysis over PD. Hemodialysis, although less convenient, is performed in a controlled clinical environment under strict medical supervision, thus reducing the risk of infections. The fear of infection and the management challenges associated with PD, especially for elderly or immunocompromised patients, can prevent wider adoption.
Segment Analysis
The global peritoneal dialysis market is segmented based on type, product type, end-user, and region.
Type:
The continuous ambulatory peritoneal dialysis (CAPD) segment is expected to dominate the peritoneal dialysis market with the highest market share
CAPD is peritoneal dialysis that can be done manually, without a machine, throughout the day. Continuous ambulatory peritoneal dialysis (CAPD) is done to remove wastes, chemicals, and extra fluid from the patient's body. During CAPD, a liquid called dialysate is put into the abdomen through a catheter (thin tube). The dialysate pulls wastes, chemicals, and extra fluid from blood through the peritoneum.
After the fluid is allowed to interact with the patient’s capillary blood, it is removed through the same permanent catheter, carrying with it the waste products like urea and creatinine. The procedure is repeated manually three times a day. Once started, CAPD has to be continued lifelong or till a renal transplantation is carried out. It offers the advantages of greater clearance of higher molecular-weight substances than during hemodialysis, good control of blood pressure, marked improvement of anemia, and unrestricted diet.
CAPD is perhaps the most uncomplicated method of carrying out dialysis as it involves the manual instillation of up to 3 L of dialysis fluid in the peritoneal cavity through an indwelling abdominal catheter four to five times a day. This typically means three or four short dwells during the day and a long dwell overnight. In adults, the total volume of fluid exchanged in a day typically ranges from 8 to 10 L. Thus, dialysis occurs continuously throughout the entire 24-hour period, and patients are free to engage in daily activities between exchanges.
Geographical Analysis
Europe is expected to hold a significant position in the global peritoneal dialysis market with the highest market share
Europe has seen significant advancements in peritoneal dialysis (PD) over the years, with increasing adoption due to its patient-friendly nature and the growing need for kidney care solutions. The region benefits from strong regulatory frameworks, which ensure high-quality standards for medical treatments, including PD.
Additionally, healthcare providers are increasingly focusing on improving patient outcomes by offering a range of innovative PD products and services. Despite challenges such as disparities in access to care across different countries, there has been a steady growth in PD usage, driven by factors such as patient preference for home-based care, cost-effectiveness, and a focus on improving quality of life.
As the European population ages and the prevalence of chronic kidney disease rises, the demand for effective and patient-centered treatments like PD will increase. The increasing prevalence of chronic kidney disease (CKD) in Europe significantly drives the demand for peritoneal dialysis (PD).
For instance, according to a report by the European Parliament in 2022, approximately 100 million individuals are affected by CKD across the European continent, and projections indicate that CKD will become the fifth leading cause of death globally by 2040. To avoid the risks of end-stage renal disease, individuals are expected to increase the adoption of peritoneal dialysis, which is considered a comfortable treatment.
Competitive Landscape
Top companies in the peritoneal dialysis market include Baxter, Fresenius Medical Care AG, BD, B. Braun Medical Inc., Mozarc Medical Holding LLC., Terumo Corporation, MITRA, Renax Biomedical Tech. Co., Ltd., Medionics, Diener Precision Pumps Ltd., and others.
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
Target Audience 2024
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Type
2.4. Snippet by Product Type
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Advancements in Peritoneal Dialysis
3.1.1.2. Rising Prevalence of Kidney Diseases
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. Risk of Infections Associated with Peritoneal Dialysis
3.1.2.2. Complications and Safety Concerns
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Expansion of Home-Based Dialysis Solutions
3.1.3.2. XX
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. Latin America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.11. Pricing Analysis and Price Dynamics
4.12. Key Opinion Leaders
5. PERITONEAL DIALYSIS MARKET, BY TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
5.1.2. Market Attractiveness Index, By Type
5.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Automated Peritoneal Dialysis (APD)
6. PERITONEAL DIALYSIS MARKET, BY PRODUCT TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Peritoneal Dialysis Solutions*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Peritoneal Dialysis Machines
6.4. Peritoneal Dialysis Catheters
6.5. Dialysis supplies
6.5.1. PD Solution Bags
6.5.2. Drain Bag
6.5.3. Cassettes and Tubing
6.5.4. Other Connection Devices
6.6. Others
7. PERITONEAL DIALYSIS MARKET, BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Homecare Settings
7.4. Dialysis Centers
7.5. Others
8. PERITONEAL DIALYSIS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. UK
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. China
8.4.6.2. India
8.4.6.3. Japan
8.4.6.4. South Korea
8.4.6.5. Rest of Asia-Pacific
8.5. South America
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. Brazil
8.5.6.2. Argentina
8.5.6.3. Rest of South America
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Baxter*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue’s
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.5. SWOT Analysis
10.2. Fresenius Medical Care AG
10.3. BD
10.4. B. Braun Medical Inc.
10.5. Mozarc Medical Holding LLC.
10.6. Terumo Corporation
10.7. MITRA
10.8. Renax Biomedical Tech. Co., Ltd.
10.9. Medionics
10.10. Diener Precision Pumps Ltd.
LIST NOT EXHAUSTIVE
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Type
2.4. Snippet by Product Type
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Advancements in Peritoneal Dialysis
3.1.1.2. Rising Prevalence of Kidney Diseases
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. Risk of Infections Associated with Peritoneal Dialysis
3.1.2.2. Complications and Safety Concerns
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Expansion of Home-Based Dialysis Solutions
3.1.3.2. XX
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. Latin America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.11. Pricing Analysis and Price Dynamics
4.12. Key Opinion Leaders
5. PERITONEAL DIALYSIS MARKET, BY TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
5.1.2. Market Attractiveness Index, By Type
5.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Automated Peritoneal Dialysis (APD)
6. PERITONEAL DIALYSIS MARKET, BY PRODUCT TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Peritoneal Dialysis Solutions*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Peritoneal Dialysis Machines
6.4. Peritoneal Dialysis Catheters
6.5. Dialysis supplies
6.5.1. PD Solution Bags
6.5.2. Drain Bag
6.5.3. Cassettes and Tubing
6.5.4. Other Connection Devices
6.6. Others
7. PERITONEAL DIALYSIS MARKET, BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Homecare Settings
7.4. Dialysis Centers
7.5. Others
8. PERITONEAL DIALYSIS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. UK
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. China
8.4.6.2. India
8.4.6.3. Japan
8.4.6.4. South Korea
8.4.6.5. Rest of Asia-Pacific
8.5. South America
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. Brazil
8.5.6.2. Argentina
8.5.6.3. Rest of South America
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Baxter*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue’s
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.5. SWOT Analysis
10.2. Fresenius Medical Care AG
10.3. BD
10.4. B. Braun Medical Inc.
10.5. Mozarc Medical Holding LLC.
10.6. Terumo Corporation
10.7. MITRA
10.8. Renax Biomedical Tech. Co., Ltd.
10.9. Medionics
10.10. Diener Precision Pumps Ltd.
LIST NOT EXHAUSTIVE
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
LIST OF TABLES
Table 1 Global Peritoneal Dialysis Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Peritoneal Dialysis Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Peritoneal Dialysis Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Peritoneal Dialysis Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Peritoneal Dialysis Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 7 Global Peritoneal Dialysis Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 9 Global Peritoneal Dialysis Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Peritoneal Dialysis Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Peritoneal Dialysis Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 14 North America Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 15 North America Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 South America Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 18 South America Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 19 South America Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 South America Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 22 Europe Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 23 Europe Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Baxter: Overview
Table 34 Baxter: Product Portfolio
Table 35 Baxter: Key Developments
Table 36 Fresenius Medical Care AG: Overview
Table 37 Fresenius Medical Care AG: Product Portfolio
Table 38 Fresenius Medical Care AG: Key Developments
Table 39 BD: Overview
Table 40 BD: Product Portfolio
Table 41 BD: Key Developments
Table 42 B. Braun Medical Inc.: Overview
Table 43 B. Braun Medical Inc.: Product Portfolio
Table 44 B. Braun Medical Inc.: Key Developments
Table 45 Mozarc Medical Holding LLC.: Overview
Table 46 Mozarc Medical Holding LLC.: Product Portfolio
Table 47 Mozarc Medical Holding LLC.: Key Developments
Table 48 Terumo Corporation: Overview
Table 49 Terumo Corporation: Product Portfolio
Table 50 Terumo Corporation: Key Developments
Table 51 MITRA: Overview
Table 52 MITRA: Product Portfolio
Table 53 MITRA: Key Developments
Table 54 Renax Biomedical Tech. Co., Ltd.: Overview
Table 55 Renax Biomedical Tech. Co., Ltd.: Product Portfolio
Table 56 Renax Biomedical Tech. Co., Ltd.: Key Developments
Table 57 Medionics: Overview
Table 58 Medionics: Product Portfolio
Table 59 Medionics: Key Developments
Table 60 Diener Precision Pumps Ltd.: Overview
Table 61 Diener Precision Pumps Ltd.: Product Portfolio
Table 62 Diener Precision Pumps Ltd.: Key Developments
Table 1 Global Peritoneal Dialysis Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Peritoneal Dialysis Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Peritoneal Dialysis Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Peritoneal Dialysis Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Peritoneal Dialysis Market Value, By Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 7 Global Peritoneal Dialysis Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 9 Global Peritoneal Dialysis Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Peritoneal Dialysis Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Peritoneal Dialysis Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 14 North America Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 15 North America Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 South America Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 18 South America Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 19 South America Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 South America Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 22 Europe Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 23 Europe Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Peritoneal Dialysis Market Value, By Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Peritoneal Dialysis Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Peritoneal Dialysis Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Peritoneal Dialysis Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Baxter: Overview
Table 34 Baxter: Product Portfolio
Table 35 Baxter: Key Developments
Table 36 Fresenius Medical Care AG: Overview
Table 37 Fresenius Medical Care AG: Product Portfolio
Table 38 Fresenius Medical Care AG: Key Developments
Table 39 BD: Overview
Table 40 BD: Product Portfolio
Table 41 BD: Key Developments
Table 42 B. Braun Medical Inc.: Overview
Table 43 B. Braun Medical Inc.: Product Portfolio
Table 44 B. Braun Medical Inc.: Key Developments
Table 45 Mozarc Medical Holding LLC.: Overview
Table 46 Mozarc Medical Holding LLC.: Product Portfolio
Table 47 Mozarc Medical Holding LLC.: Key Developments
Table 48 Terumo Corporation: Overview
Table 49 Terumo Corporation: Product Portfolio
Table 50 Terumo Corporation: Key Developments
Table 51 MITRA: Overview
Table 52 MITRA: Product Portfolio
Table 53 MITRA: Key Developments
Table 54 Renax Biomedical Tech. Co., Ltd.: Overview
Table 55 Renax Biomedical Tech. Co., Ltd.: Product Portfolio
Table 56 Renax Biomedical Tech. Co., Ltd.: Key Developments
Table 57 Medionics: Overview
Table 58 Medionics: Product Portfolio
Table 59 Medionics: Key Developments
Table 60 Diener Precision Pumps Ltd.: Overview
Table 61 Diener Precision Pumps Ltd.: Product Portfolio
Table 62 Diener Precision Pumps Ltd.: Key Developments
LIST OF FIGURES
Figure 1 Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 3 Global Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 4 Global Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Peritoneal Dialysis Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Peritoneal Dialysis Market Y-o-Y Growth, By Type, 2023-2033 (%)
Figure 7 Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 8 Automated Peritoneal Dialysis (APD) Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 9 Global Peritoneal Dialysis Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 10 Peritoneal Dialysis Solutions Product Type in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 11 Peritoneal Dialysis Machines Product Type in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 12 Peritoneal Dialysis Catheters Product Type in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 13 Dialysis supplies Product Type in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 14 Other Product Types in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 15 Global Peritoneal Dialysis Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 16 Hospitals End-User in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 17 Homecare Settings End-User in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 18 Dialysis Centers End-User in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 19 Other End-Users in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 20 Global Peritoneal Dialysis Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 21 North America Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 22 North America Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 23 North America Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 24 North America Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 25 North America Peritoneal Dialysis Market Share, By Country, 2024 & 2033 (%)
Figure 26 South America Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 27 South America Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 28 South America Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 29 South America Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 30 South America Peritoneal Dialysis Market Share, By Country, 2024 & 2033 (%)
Figure 31 Europe Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 32 Europe Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 33 Europe Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 34 Europe Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 35 Europe Peritoneal Dialysis Market Share, By Country, 2024 & 2033 (%)
Figure 36 Asia-Pacific Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 37 Asia-Pacific Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 38 Asia-Pacific Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 39 Asia-Pacific Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 40 Asia-Pacific Peritoneal Dialysis Market Share, By Country, 2024 & 2033 (%)
Figure 41 Middle East and Africa Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 42 Middle East and Africa Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 43 Middle East and Africa Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 44 Middle East and Africa Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 45 Baxter: Financials
Figure 46 Fresenius Medical Care AG: Financials
Figure 47 BD: Financials
Figure 48 B. Braun Medical Inc.: Financials
Figure 49 Mozarc Medical Holding LLC.: Financials
Figure 50 Terumo Corporation: Financials
Figure 51 MITRA: Financials
Figure 52 Renax Biomedical Tech. Co., Ltd.: Financials
Figure 53 Medionics: Financials
Figure 54 Diener Precision Pumps Ltd.: Financials
Figure 1 Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 3 Global Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 4 Global Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Peritoneal Dialysis Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Peritoneal Dialysis Market Y-o-Y Growth, By Type, 2023-2033 (%)
Figure 7 Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 8 Automated Peritoneal Dialysis (APD) Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 9 Global Peritoneal Dialysis Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 10 Peritoneal Dialysis Solutions Product Type in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 11 Peritoneal Dialysis Machines Product Type in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 12 Peritoneal Dialysis Catheters Product Type in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 13 Dialysis supplies Product Type in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 14 Other Product Types in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 15 Global Peritoneal Dialysis Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 16 Hospitals End-User in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 17 Homecare Settings End-User in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 18 Dialysis Centers End-User in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 19 Other End-Users in Global Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 20 Global Peritoneal Dialysis Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 21 North America Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 22 North America Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 23 North America Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 24 North America Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 25 North America Peritoneal Dialysis Market Share, By Country, 2024 & 2033 (%)
Figure 26 South America Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 27 South America Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 28 South America Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 29 South America Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 30 South America Peritoneal Dialysis Market Share, By Country, 2024 & 2033 (%)
Figure 31 Europe Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 32 Europe Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 33 Europe Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 34 Europe Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 35 Europe Peritoneal Dialysis Market Share, By Country, 2024 & 2033 (%)
Figure 36 Asia-Pacific Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 37 Asia-Pacific Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 38 Asia-Pacific Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 39 Asia-Pacific Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 40 Asia-Pacific Peritoneal Dialysis Market Share, By Country, 2024 & 2033 (%)
Figure 41 Middle East and Africa Peritoneal Dialysis Market Value, 2022-2033 (US$ Billion)
Figure 42 Middle East and Africa Peritoneal Dialysis Market Share, By Type, 2024 & 2033 (%)
Figure 43 Middle East and Africa Peritoneal Dialysis Market Share, By Product Type, 2024 & 2033 (%)
Figure 44 Middle East and Africa Peritoneal Dialysis Market Share, By End-User, 2024 & 2033 (%)
Figure 45 Baxter: Financials
Figure 46 Fresenius Medical Care AG: Financials
Figure 47 BD: Financials
Figure 48 B. Braun Medical Inc.: Financials
Figure 49 Mozarc Medical Holding LLC.: Financials
Figure 50 Terumo Corporation: Financials
Figure 51 MITRA: Financials
Figure 52 Renax Biomedical Tech. Co., Ltd.: Financials
Figure 53 Medionics: Financials
Figure 54 Diener Precision Pumps Ltd.: Financials
